Bharat Parenter.

Bharat_Parenter.29 Apr 2024

Pharmaceuticals

₹

+44.05 (+2.58%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Bharat Parenter.

Bharat Parenter.

Pharmaceuticals

Bharat_Parenter.29 Apr 2024

₹

+44.05 (+2.58%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
20-May-2023	D	In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on 20th May, 2023, has considered and approved the Audited Financial Results for the Quarter and year ended 31st March, 2023 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. The Board has also recommended payment of final dividend of Rs. 0.75 (Rupees Seventy-Five Paise Only) per Equity Share of Rs. 10/- each (fully paid-up) for the financial year ended March 31, 2023 and the same shall be payable subject to approval of the Shareholders at the ensuing Annual General Meeting ('AGM') of the Company.	25-Sep-2023
25-Apr-2024	BC	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2024 inter alia to consider and approve Intimation of Board Meeting under regula	29-Apr-2024
31-Jan-2024	BC	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Board meeting for Adoption of unaudited	13-Feb-2024
10-Jan-2024	BC	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Thursd	11-Jan-2024
01-Nov-2023	BC	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve To Consider unaudutied Financial Result	09-Nov-2023
02-Oct-2023	BC	Intimation for Resignation of Company Secretary cum Compliance officer Additional Details required for corporate Announcement filed with SEBI for Announcement of Resignation of Company Secretary /	02-Oct-2023

No Rights has been declared by Bharat_Parenter.

Book Closure

Record Date	Split Date	Purpose
29-Apr-2024	-	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2024 inter alia to consider and approve Intimation of Board Meeting under regula
13-Feb-2024	-	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Board meeting for Adoption of unaudited
11-Jan-2024	-	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Thursd
09-Nov-2023	-	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve To Consider unaudutied Financial Result
02-Oct-2023	-	Intimation for Resignation of Company Secretary cum Compliance officer Additional Details required for corporate Announcement filed with SEBI for Announcement of Resignation of Company Secretary /

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Bharat Parenterals Ltd ₹1,750.00(+44.05/2.58%)	1,750.00	+44.05	985.13	404.72	34.19	4.78
Astrazeneca Pharma India Ltd ₹5,530.75(+115.35/2.13%)	5,530.75	+115.35	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹124.65(+2.05/1.67%)	124.65	+2.05	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,395.75(-13.65/-0.97%)	1,395.75	-13.65	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹25,960.00(+95.15/0.37%)	25,960.00	+95.15	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹700.45(+19.60/2.88%)	700.45	+19.60	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	58.80	59.81	69.91	50.97	59.02	81.90
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	58.80	59.81	69.91	50.97	59.02	81.90
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	2.40	3.46	2.86	6.96	3.95	6.39
Total Income	61.20	63.27	72.77	57.93	62.97	88.29
Total Expenditure	52.02	53.38	58.42	44.38	55.51	72.56
PBIDT	9.18	9.89	14.35	13.55	7.46	15.73
Interest	0.61	0.61	0.88	0.80	0.79	0.34
PBDT	8.57	9.28	13.47	12.75	6.67	15.39
Depreciation	1.67	1.61	1.51	1.43	1.43	1.45
Tax	2.22	1.64	3.21	2.76	1.35	3.80
Deferred Tax	-0.39	0.47	-0.14	-0.73	0.08	0.15
Reported Profit After Tax	5.07	5.56	8.89	9.29	3.81	9.99
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	5.07	5.56	8.89	9.29	3.81	9.99

EPS (Unit Curr.)	8.65	9.62	15.40	16.19	6.60	17.30
EPS (Adj) (Unit Curr.)	8.65	9.62	15.40	16.19	6.60	17.30
Calculated EPS (Unit Curr.)	8.79	9.64	15.41	16.10	6.60	17.31
Calculated EPS (Adj) (Unit Curr.)	8.79	9.64	15.41	16.10	6.60	17.31
Calculated EPS (Ann.) (Unit Curr.)	35.15	38.54	61.63	64.40	26.41	69.25
Calculated EPS (Adj) (Ann.) (Unit Curr.)	35.15	38.54	61.63	64.40	26.41	69.25
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	5.77	5.77	5.77	5.77	5.77	5.77
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	15.61	16.54	20.53	26.58	12.64	19.21
PBDTM(%)	14.57	15.52	19.27	25.01	11.30	18.79
PATM(%)	8.62	9.30	12.72	18.23	6.46	12.20

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	59.82	59.81	69.91	50.97	59.02	81.90
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	59.82	59.81	69.91	50.97	59.02	81.90
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	1.26	2.60	2.10	0.31	3.48	6.41
Total Income	61.08	62.41	72.01	51.28	62.50	88.31
Total Expenditure	53.21	55.49	59.46	44.75	56.38	72.71
PBIDT	7.87	6.92	12.55	6.53	6.12	15.60
Interest	0.58	0.63	0.89	0.80	0.79	0.34
PBDT	7.29	6.29	11.66	5.73	5.33	15.26
Depreciation	1.82	1.75	1.58	1.44	1.44	1.46
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	2.22	1.55	3.21	2.76	1.35	3.80
Deferred Tax	-0.39	0.56	-0.14	-0.74	0.07	0.15
Reported Profit After Tax	3.64	2.43	7.01	2.27	2.47	9.85
Minority Interest After NP	-0.14	-1.09	-0.51	-0.22	-0.38	-0.07
Net Profit after Minority Interest	3.78	3.52	7.52	2.49	2.85	9.92

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	3.78	3.52	7.52	2.49	2.85	9.92

EPS (Unit Curr.)	6.45	6.07	13.03	4.24	4.94	17.19
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	5.77	5.77	5.77	5.77	5.77	5.77

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	13.16	11.57	17.95	12.81	10.37	19.05
PBDTM(%)	12.19	10.52	16.68	11.24	9.03	18.63
PATM(%)	6.08	4.06	10.03	4.45	4.19	12.03

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	5.77	5.77	5.73	5.73	5.73	5.73
Reserves Total	185.29	160.38	138.21	117.41	91.07	68.59
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	191.06	166.15	143.94	123.14	96.80	74.32
Secured Loans	42.91	12.53	9.78	1.30	4.84	8.76
Unsecured Loans	2.80	2.48	2.46	0.00	0.00	0.00
Total Debt	45.71	15.01	12.24	1.30	4.84	8.76
Total Liabilities	236.77	181.16	156.18	124.44	101.64	83.08
APPLICATION OF FUNDS :
Gross Block	75.62	74.48	72.55	55.08	51.62	44.11
Less : Accumulated Depreciation	39.36	33.64	27.99	22.02	16.28	10.40
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	36.26	40.84	44.56	33.06	35.34	33.71
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.62	0.00	12.16	1.06	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	38.40	16.30	41.82	0.26	1.72	0.77
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	37.84	20.76	22.43	27.69	21.10	14.43
Sundry Debtors	112.40	73.40	67.83	81.70	65.65	58.92
Cash and Bank	7.43	4.61	2.16	9.99	11.95	4.09
Loans and Advances	16.84	33.11	12.81	16.79	19.96	13.86
Total Current Assets	174.51	131.88	105.23	136.17	118.65	91.30
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	67.91	32.97	36.60	64.47	55.47	47.09
Provisions	1.61	1.99	0.84	0.67	0.71	3.13
Total Current Liabilities	69.52	34.95	37.44	65.14	56.18	50.22
Net Current Assets	104.99	96.93	67.79	71.03	62.47	41.08
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1.03	0.82	0.29	0.24	0.19	2.22
Deferred Tax Liability	1.43	1.78	2.26	2.44	3.54	0.02
Net Deferred Tax	-0.40	-0.96	-1.97	-2.20	-3.35	2.20
Total Assets	179.25	153.73	152.20	114.31	97.24	77.76
Contingent Liabilities	26.69	22.78	31.45	26.24	22.06	20.53

Column	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
SOURCES OF FUNDS :
Share Capital	5.77	5.73	5.73	5.73	5.73	5.73
Reserves Total	160.05	138.14	112.46	88.28	67.12	57.95
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	165.82	143.87	118.19	94.01	72.85	63.68
Minority Interest	4.32	-0.05	0.00	0.00	0.00	0.00
Secured Loans	12.53	9.78	1.30	4.84	3.78	6.07
Unsecured Loans	5.22	2.46	0.00	0.00	4.98	0.34
Total Debt	17.75	12.24	1.30	4.84	8.76	6.41
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.94	0.64	0.51	0.09	0.00	0.00
Total Liabilities	188.83	156.70	120.00	98.94	81.61	70.09
APPLICATION OF FUNDS :
Gross Block	74.48	72.55	55.08	51.62	44.11	35.99
Less: Accumulated Depreciation	33.64	27.99	22.02	16.28	10.40	4.83
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	40.84	44.56	33.06	35.34	33.71	31.16
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	25.65	0.44	12.16	1.06	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	11.48	42.79	0.01	1.47	0.52	0.55
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	20.76	22.43	28.82	22.52	14.43	15.27
Sundry Debtors	73.40	67.83	79.35	63.87	58.65	43.60
Cash and Bank	4.68	2.43	10.40	12.13	4.13	1.58
Loans and Advances	33.41	12.54	13.04	18.03	13.10	3.53
Total Current Assets	132.26	105.23	131.61	116.55	90.30	63.98
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	34.29	39.14	64.63	55.93	47.33	40.18
Provisions	1.99	0.84	0.67	0.71	3.13	0.21
Total Current Liabilities	36.27	39.98	65.30	56.64	50.46	40.39
Net Current Assets	95.98	65.25	66.32	59.91	39.84	23.59
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.82	0.29	0.24	0.19	2.22	0.72
Deferred Tax Liability	1.78	2.26	2.44	3.54	0.10	0.00
Net Deferred Tax	-0.96	-1.97	-2.20	-3.35	2.12	0.72
Other Assets	15.83	5.63	10.66	4.51	5.41	14.07
Total Assets
Contingent Liabilities	22.78	31.45	26.24	22.06	20.53	17.80

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	3.33	1.40	9.69	10.88	3.85
Net Cash from Operating Activities	-11.56	-22.08	21.87	14.48	20.28
Net Cash Used In Investing Activities	-13.95	21.76	-40.71	-12.60	-9.35
Net Cash Used In Financing Activities	28.52	2.24	10.55	-3.07	-3.89
Net Inc./Dec In Cash And Cash Equivalents	3.01	1.93	-8.29	-1.19	7.03
Cash And Cash Equivalents At End Of The Year	6.34	3.33	1.40	9.69	10.88

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

73.27%

FII Shareholding

0.00%

DII Shareholding

0.01%

Public Shareholding

26.73%

**Promoter pledged shareholding 73.27%

About Bharat Parenterals Ltd

Bharat Parenterals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 985.13 crores. It has reported a sales of Rs. 58.8 crores and a net profit of Rs. 5.07 crores for the quarter ended December 2018. The company management includes , Bharat Kumar R Desai,Hemang Jayendrabhai Shah,Shaileshkumar Ghabhawala,Zankhana Sheth,Mukesh Patel,Sanjay Shah,SHYAM SINGH RAJPUROHIT (Bharat Parenterals Ltd) among others.

Chairman

Registered office

Survey No 144 & 146 Haripura,Jarod Samlaya Road Tal Savli,Vadodara,Gujarat,391520

FAX :91-2667-251670

Background

Incorporation Year1992

Face Value₹10

Market Lot1

How to buy Bharat Parenter. shares on nse?

To buy Bharat Parenter. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Bharat Parenter. share price today?

The Bharat Parenter. shares price on nse is Rs.1750 today.

What is the market cap of Bharat Parenter. shares on BSE ?

The company has a market capitalization of Rs.985.13Cr

What is the PE & PB ratio of Bharat Parenter. shares ?

PE is 34.19 and PB is 4.78

What is the 52 Week High and Low of Bharat Parenter. shares?

Bharat Parenter. stock price high: Rs.1791.2 Bharat Parenter. stock price low: Rs.321.2